Literature DB >> 1739321

Trial of intensive compared with weekly speech therapy in preschool children.

J Barratt1, P Littlejohns, J Thompson.   

Abstract

Forty two preschool children referred to a speech therapy department were randomly allocated to receive intensive individual speech therapy or the more traditional once weekly approach. Boys and minority ethnic groups were referred most frequently. Speech therapy improved expression more than comprehension, as measured on Reynell scales. The mean improvements were 0.5 SDs (95% confidence intervals (CI) 0.3 to 0.7) and 0.3 (95% CI 0.1 to 0.5) respectively. There was a greater improvement in children receiving intensive compared with weekly therapy in the expression scores (0.8 SDs (95% CI 0.5 to 1.1) v 0.2 SDs (95% CI -0.1 to 0.5]. White and non-white children had similar improvements in comprehension scores but white children had greater improvement in expression scores (1.1 SDs v 0.3 SDs). This difference was seen in both therapy groups. Randomised trials are useful in the evaluation of speech therapy in children.

Entities:  

Mesh:

Year:  1992        PMID: 1739321      PMCID: PMC1793542          DOI: 10.1136/adc.67.1.106

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

Review 1.  Trials and tribulations in speech therapy.

Authors:  C M Allen
Journal:  BMJ       Date:  1990-08-11

2.  Randomised clinical trials with clinician-preferred treatment.

Authors:  E L Korn; S Baumrind
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

3.  The outcomes movement--will it get us where we want to go?

Authors:  A M Epstein
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  Delayed speech in children.

Authors:  D Hall
Journal:  BMJ       Date:  1988-11-19

5.  The child who is slow to talk.

Authors:  R J Robinson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
  5 in total
  8 in total

1.  Studying the impact of intensity is important but complicated.

Authors:  Paul Yoder; Marc E Fey; Steven F Warren
Journal:  Int J Speech Lang Pathol       Date:  2012-05-31       Impact factor: 2.484

2.  Effects of dose frequency of early communication intervention in young children with and without Down syndrome.

Authors:  Paul Yoder; Tiffany Woynaroski; Marc Fey; Steven Warren
Journal:  Am J Intellect Dev Disabil       Date:  2014-01

3.  Dose Schedule and Enhanced Conversational Recast Treatment for Children With Specific Language Impairment.

Authors:  Christina N Meyers-Denman; Elena Plante
Journal:  Lang Speech Hear Serv Sch       Date:  2016-10-01       Impact factor: 2.983

4.  Is more better? Milieu communication teaching in toddlers with intellectual disabilities.

Authors:  Marc E Fey; Paul J Yoder; Steven F Warren; Shelley L Bredin-Oja
Journal:  J Speech Lang Hear Res       Date:  2012-12-28       Impact factor: 2.297

5.  Targeting Complex Sentences in Older School Children With Specific Language Impairment: Results From an Early-Phase Treatment Study.

Authors:  Catherine H Balthazar; Cheryl M Scott
Journal:  J Speech Lang Hear Res       Date:  2018-03-15       Impact factor: 2.297

6.  Improving outcomes of preschool language delay in the community: protocol for the Language for Learning randomised controlled trial.

Authors:  Melissa Wake; Penny Levickis; Sherryn Tobin; Naomi Zens; James Law; Lisa Gold; Obioha C Ukoumunne; Sharon Goldfeld; Ha N D Le; Jemma Skeat; Sheena Reilly
Journal:  BMC Pediatr       Date:  2012-07-09       Impact factor: 2.125

7.  Maximizing Treatment Efficiency in Developmental Language Disorder: Positive Effects in Half the Time.

Authors:  Elena Plante; Heidi M Mettler; Alexander Tucci; Rebecca Vance
Journal:  Am J Speech Lang Pathol       Date:  2019-07-25       Impact factor: 4.018

8.  Cost of speech-language interventions for children and youth with foetal alcohol spectrum disorder in Canada.

Authors:  Svetlana Popova; Shannon Lange; Larry Burd; Kevin Shield; Jürgen Rehm
Journal:  Int J Speech Lang Pathol       Date:  2013-12-18       Impact factor: 2.484

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.